Teradyne: Tariffs, Short-Term Headwinds, But Undervalued
Portfolio Pulse from
Teradyne is facing short-term headwinds due to tariffs but is considered undervalued. The company has a revised revenue growth outlook for 2025 of 5%-10% and mid-term growth expected at 12%-18% through 2028. The base case DCF derived Fair Value is $115.7, indicating a 33% upside from the current price.
March 14, 2025 | 10:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Teradyne is facing short-term challenges due to tariffs but is considered undervalued with a potential 33% upside based on a Fair Value of $115.7. The company has a revised revenue growth outlook for 2025 of 5%-10% and mid-term growth expected at 12%-18% through 2028.
The article highlights Teradyne's potential upside despite short-term challenges. The Fair Value of $115.7 suggests a 33% upside from the current price, indicating a positive short-term impact on the stock price. The revenue growth outlook supports this positive view.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100